Part of UT Health San Antonio

Part of UT Health San Antonio

You are here

Kimberly summers

Contact

210-567-8355

summers@uthscsa.edu

Departments & Divisions

Kimberly K. Summers, Pharm.D.

Director

Research Protection Programs; Adjoint Assistant Professor

Kimberly Summers, PharmD is the Director of Research Protection Programs at the University of Texas Health San Antonio (UT Health SA). Dr. Summers has direct oversight of the functions and responsibilities of the Institutional Review Board (IRB), the Institutional Animal Care and Use Committee (IACUC), Office of Clinical Research (OCR), and the administrative offices that support them. Dr. Summers received her PharmD degree from the University of Missouri-Kansas City and completed a residency and fellowship in Infectious Diseases at UT Health and the South Texas Veterans Health Care System (STVHCS) in San Antonio. Her research and early publications looked at the pharmacokinetic/pharmacodynamic actions of antifungals, antivirals, and antimicrobial agents. Dr. Summers has contributed to the scientific literature describing antiretroviral therapeutic approaches and collaborated with several national and international groups in the development of recommended treatment strategies for HIV infected individuals. Dr. Summers has been serving in leadership roles in human subject protections and research oversight since 2007. In her current position, she has been able to successfully implement several IRB authorization agreements in which UT Health SA has served as either the reviewing IRB or a relying institution for multi-site collaborative research. She has developed an institutional review and oversight process which has worked for each external IRBs unique structure and function. This has given her critical insight into the importance of institutional oversight for human research protections and the challenges of implementing signal IRB review. As a SMART IRB Ambassador for Texas, she is currently working with national groups to implement the policies and practices for NIH single IRB review for clinical trials. This role includes membership on the SMART IRB Harmonization Steering Committee (HSC), and serving as the co-lead for the SMART IRB HSC Local/State Requirements ad-hoc Committee. 

  • Professional Background

    Education

    • 1997 - Postdoctoral Fellowship - Infectious Disease - The University of Texas Health Science Center at San Antonio
    • 1996 - Residency - Pharmacy Specialty - The University of Texas Health Science Center & South Texas Veterans Health
    • 1995 - PharmD - Pharmacy - University of Missouri-Kansas City
    • 1989 - University of Missouri-Columbia

    Appointments

    • 12/2007 - Assistant Chief - South Texas Veterans Health Care System, Clinical Research, San Antonio
    • 7/1997 - Clinical Assistant Professor - The University of Texas College of Pharmacy & The University of Texas Health Science Center, Pharmacology, Austin & San Antonio

  • Instruction & Training

    • 1/2005 - Present, PHR Advanced Infectious Disease Pharmacotherapy
    • 1/2004 - Present, South Texas Veterans Health Care System
    • 1/2002 - Present, PHR 381W Molecular and Pharm Basis Therapeutics, The University of Texas Health Science Center at San Antonio
    • 1/2000 - Present, PHR 285F/PHR 275 Pharmacotherapy 3B
    • 1/2000 - Present, Pharmacotherapy Seminar
    • 1/1999 - Present, The University of Texas The University of Texas Health Science Center at Austin San Antonio, TX
    • 1/1999 - Present, South Texas Veterans Health Care System
    • 1/1999 - Present, PHR 593S Clinical Clerkship

  • Research & Grants

    Grants

    Federal

    Funding Agency OPTIMA Title Multi-site, VA collaborative Trial evaluating HIV salvage treatment in HIV infected patients Status Active Period 1/2001 - Present Role Co-Investigator Grant Detail

    Private

    Funding Agency ADVENT Title Multi-site study of efficacy and safety of Crofelemer for HIV associated diarrhea Status Active Period 1/2006 - Present Role Co-Principal Investigator Grant Detail Funding Agency Title Multi-site phase III trial to evaluate the pharmacokinetics of efavirenz in patients with liver disease Status Active Period 1/2006 - Present Role Co-Investigator Grant Detail Funding Agency SMART Title Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)-NIAID-funded to conduct community-based research on treatment, prevention, and allied questions affecting persons with HIV/AIDS Status Active Period 1/2003 - Present Role Principal Investigator Grant Detail Funding Agency Title Study sponsored by Emergent Product Development to evaluate 3 doses of Biothrax for post-exposure prophylaxis in normal volunteers Status Active Period 1/2006 - Present Role Co-Investigator Grant Detail

     

    Funding Agency SILCAAT Title Multi-site international NIH-funded trial of Interleukin-2 for persons with HIV Status Active Period 1/2001 - Present Role Principal Investigator Grant Detail